期刊文献+

内蒙古地区弥漫性大B细胞淋巴瘤50例临床病理分析

Diffuse large B cell lymphoma in Inner Mongolia area:a clinicopathological analysis of 50 cases
下载PDF
导出
摘要 目的探讨弥漫性大B细胞淋巴瘤(DLBCL)的免疫表型特点。方法收集不同部位的DLBCL50例,通过免疫组化方法检测DLBCL的免疫表型并进行分类。结果50例CD20和CD79a均(+),13例CD45RO(+),5例CD43(+),17例CD10(+),25例bcl-6(+),28例MUM-1(+)。根据免疫表型分类,21例为生发中心B细胞样DLBCL,29例为活化B细胞样DLBCL。结论内蒙古地区DLBCL的发病部位涉及多个器官和组织,其中以颈部、扁桃体和胃肠道为多见。该地区DLBCL病例B细胞标记物CD20和CD79a均(+),部分病例T细胞标记物CD45RO(+),这可能是内蒙古地区DLBCL病例的特点。 Purpose To investigate the immunophenotypic feature of diffuse large B cell lymphoma (DLBCL). Methods 50 cases of DLBCL were detemfined with immunohistochemical staining, and distinguished from other cases according to their immunophenotypic features. A penal of antibodies CD20, CD3, CD79a, CIM3, CD45RO, CD10, bcl-6 and MUM-1 were used in this study. Results All of the cases expressed CD20 and CD79a; CD45RO, CD43, CD10, bcl-6 and MUM-1 were expressed in 13 cases, 5 cases, 17 cases, 25 cases and 28 cases, respectively; According to the immunophentypes, 21 cases were classified as germinal center B-cell-like DLBCL, and the other 29 cases as activated B-cell-like DLBCL. Conclusions The DLBCL in Inner Mongolia are localized in multiple organs or tissues, most commonly in the neck, tonsil and gastrointestinal tract, which express the markers of B cells CD20 and CD79a in all cases, and CD45RO, a T cell marker, in some cases. Maybe it is the feature of DLBCL cases in the Inner Mongolia.
出处 《诊断病理学杂志》 CSCD 2009年第1期29-31,共3页 Chinese Journal of Diagnostic Pathology
关键词 弥漫性大B细胞淋巴瘤 免疫组化 临床病理 DLBCL Immunohistochmistry Clinical pathology
  • 相关文献

参考文献6

  • 1姚丽青,郑智勇,刘秉瀚,余英豪,申洪,曾玲.弥漫大B细胞性淋巴瘤分子亚型的蛋白表达研究[J].中国肿瘤临床,2007,34(5):241-244. 被引量:10
  • 2Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray[J]. Blood,2004,103 (1):275-282.
  • 3Jaffe KS, Harris NL, Stein HEA.造血与淋巴组织肿瘤病理学和遗传学[M].周小鸽,陈辉树主译.北京:人民卫生出版社,2006.171-175.
  • 4Sjo LD, Poulsen CB, Hansen M, et al. Profiling of diffuse large B- cell lymphoma by immunohistochemistry: identification of prognostic subgroups. [J]. Eur J Haematol,2007,79(6) :501 - 507.
  • 5Yeelken H, Vik Dannheim S, Schulte Moenting J, et al. Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy. [J]. Ann Oncol,2007,18(5) :931 - 939.
  • 6van Imhoff G W, Boerma EJ, van er Holt B, et al. Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma. [J]. J Clin Oncol, 2006,24(25) :4135 - 4142.

二级参考文献9

  • 1Hans CP, Weisenburger DD, Greiner TC,et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a ussue microarray [J]. Blood, 2004, 103(1): 275-282.
  • 2Jaffy ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues [M]. Lyon: IARC Press, 2001. 111-113.
  • 3Rossi D, Gaidano G. Molecular heterogeneity of diffuse large Bcell lymphoma: implications for disease management and prognosis[J]. Hematology, 2002, 7(4): 239-252.
  • 4Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling[J]. Nature, 2000, 403(6769): 503-511.
  • 5Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large B--cell lymphoma[J]. N Engl J Med, 2002, 346(25): 1937-1947.
  • 6Shipp MA, Ross KN, Tamayo P, et al. Diffuse large B-cell lym- phoma outcome prediction by gene--expression profiling and su- pervised machine learning[J]. Nat Med, 2002, 8(1): 68-74.
  • 7GoJH, Yang WI, Ree HJ. CD10 expression in primary intestinal large B---cell lymphomas: its clinical significance [J]. Arch Pathol Lab Med, 2002, 126(8): 956-960.
  • 8Colomo L, Lopez--Guillermo A, Perales M, et al. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma [J]. Blood, 2003, 101 (1): 78-84.
  • 9Lossos IS, Jones CD, Wamke R, et al. Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B---cell lymphoma[J]. Blood, 2001, 98(4): 945-951.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部